UK Life Sciences Facilities & Expansion News
Facilities and expansion news covers the physical infrastructure that supports science, manufacturing and commercial operations. The category follows substantive developments at laboratories, science parks, research campuses and production sites connected to UK life sciences.
Codis Begins Construction of PSD-4 Spray-Drying Facility in Haverhill
Codis has completed demolition work and begun construction of a PSD-4 spray-drying facility at its Haverhill manufacturing site. The investment will add solvent-capable commercial-scale capacity for amorphous solid dispersions, complementing the company's existing PSD-2 equipment and formulation services in Nottingham. Codis expects the new capacity to become available in the final quarter of 2027, subject to installation and validation.
Gifford Bioscience Opens Dedicated Radiometric Laboratory at BioHub Birmingham
Gifford Bioscience has opened a dedicated radiometric laboratory at BioHub Birmingham, where it has been based since 2017. The lab supports radioligand binding, quantitative autoradiography, uptake and release, and receptor occupancy studies.
Sterling Pharma Solutions Doubles Capacity at Deeside ADC Facility
Sterling Pharma Solutions has completed an expansion of its Deeside facility that doubles its manufacturing capacity, adding a 500-litre reactor and a new GMP suite with a 1,400 sq ft Grade C cleanroom. A new 3,400 sq ft analytical laboratory with expanded HPLC/UPLC capacity supports the site, which can handle compounds down to OEB 5 exposure limits.
Upperton Secures MHRA Approval for New Sterile Manufacturing Facility
Upperton has secured MHRA approval to bring its new Annex 1-aligned sterile manufacturing facility at Trent Gateway, Nottingham, within the scope of its existing MIA(IMP) licence, allowing it to begin GMP manufacture of sterile investigational medicinal products. The 7,000 sq ft facility, designed for small-scale aseptic and terminally sterilised drug product manufacture, sits alongside Upperton's existing 50,000 sq ft development and clinical manufacturing site, extending its offering to include sterile fill-finish for early-phase clinical programmes.
Croda Opens Global Biotechnology Centre at Sci-Tech Daresbury
Croda International has officially opened new biotechnology R&D laboratories at Sci-Tech Daresbury, designating the site its global centre for biotechnology research. The facility, formally opened by Minister for Reindustrialisation Blair McDougall MP and Liverpool City Region Mayor Steve Rotheram, is expected to support future job creation both at Daresbury and Croda's other four UK sites, and has already produced KeraBio K31, a biotech-derived keratin ingredient now being commercialised globally.